Cryoniss
Cryoniss is a UK-based life sciences company specializing in temperature-controlled biological sample storage and logistics services. Founded by former senior leaders of AstraZeneca, Sonia Houghton and Phil Hargreaves, it provides secure, ethical, and compliant storage solutions for biological samples, supporting drug discovery, clinical trials, and life cycle management. As part of the Biofortuna Group since May 2024, Cryoniss operates state-of-the-art facilities in the UK, offering next-day access to samples across the UK and internationally. The company's core services include biobanking, cell banking, bioreagent storage, QC testing, clinical sample storage, medicinal product storage, and support for COVID-19 samples, with a strong emphasis on quality, compliance, and ethical standards.
Industries
Nr. of Employees
small (1-50)
Cryoniss
Macclesfield, Cheshire East, United Kingdom, Europe
Services
Sourced, managed and accessible storage for human and research biological samples across controlled temperature ranges.
Long‑term storage and management of master and archival cell banks and options for cultured cell bank supply.
Production and supply of cultured cell banks with quality and consistency for research use.
Secure storage of manufactured bioreagents and diagnostic kit master stocks with cloud‑based traceability.
Weekly coordination of routine QC screens such as mycoplasma testing and cell line authentication via partner contract research organisations, with consolidated logistics and reporting.
End‑to‑end logistics including packaging provision, dry‑ice deliveries, courier coordination and consignment paperwork for domestic and international shipments.
Sourced, managed and accessible storage for human and research biological samples across controlled temperature ranges.
Long‑term storage and management of master and archival cell banks and options for cultured cell bank supply.
Production and supply of cultured cell banks with quality and consistency for research use.
Secure storage of manufactured bioreagents and diagnostic kit master stocks with cloud‑based traceability.
Weekly coordination of routine QC screens such as mycoplasma testing and cell line authentication via partner contract research organisations, with consolidated logistics and reporting.
End‑to‑end logistics including packaging provision, dry‑ice deliveries, courier coordination and consignment paperwork for domestic and international shipments.
Expertise Areas
- Biobanking and sample storage management
- Cold-chain logistics and sample transport
- Cell banking and cell culture provision
- Clinical trial sample and IMP handling
Key Technologies
- Vapour-phase liquid nitrogen storage
- Ultra-low temperature (-80°C) freezer storage
- Cold-chain packaging and dry-ice shipping
- Cloud-based sample and reagent inventory systems
News & Updates
Cryoniss became part of the Biofortuna Group in May 2024, expanding its services and reach.
Cryoniss opened its second facility at The Heath Business & Technical Park in Runcorn, expanding storage capacity for biological samples.
The new facility supports ambient to -80°C storage, with advanced security and management.
The article discusses the branding principles of Cryoniss, emphasizing trust, sophistication, and expert service in biological sample storage.
Cryoniss shares insights on its compliance with cGMP standards and customer-focused quality management.
Cryoniss was nominated for the prestigious Bionow Start Up of the Year award in 2021.
Cryoniss became part of the Biofortuna Group in May 2024, expanding its services and reach.
Cryoniss opened its second facility at The Heath Business & Technical Park in Runcorn, expanding storage capacity for biological samples.
The new facility supports ambient to -80°C storage, with advanced security and management.
The article discusses the branding principles of Cryoniss, emphasizing trust, sophistication, and expert service in biological sample storage.
Cryoniss shares insights on its compliance with cGMP standards and customer-focused quality management.
Cryoniss was nominated for the prestigious Bionow Start Up of the Year award in 2021.